Lipex

Hypolipemiant. IHMG-CoA reductase inhibitor. Indicated to treat hypercholesterolemia, dyslipidemias, dysbetalipoproteinemia and for the prevention of more severe cardiovascular events in patients at high cardiovascular risk.

Therapeutic Area
Hypercholesterolemia

Active Ingredient
Rosuvastatine

Line
Cardiometabolism + Endocrinology

Pharmaceutical Forms
5 mg coated tablets x 30
10 mg coated tablets x 30
20 mg coated tablets x 30
40 mg coated tablets x 30

Download Leaflet Descargar